Browsing: BMO

Investing.com– President-elect Donald Trump’s selection of Martin Makary as FDA commissioner has been welcomed by the BioPharma sector, with investors…

BMO Capital analysts reiterated an Outperform rating and Cdn$17.00 price target on Obsidian Energy Ltd. (CN) (OBE). The analysts comment…